GASTROINTESTINAL MOTILITY DISORDERS DURING PREGNANCY

被引:120
作者
BARON, TH [1 ]
RAMIREZ, B [1 ]
RICHTER, JE [1 ]
机构
[1] UNIV ALABAMA, DIV GASTROENTEROL, UAB STN, UNIVERSITY, AL 35486 USA
关键词
GASTROINTESTINAL MOTILITY; PREGNANCY COMPLICATIONS; GASTROESOPHAGEAL REFLUX; NAUSEA; VOMITING;
D O I
10.7326/0003-4819-118-5-199303010-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To review the pathophysiology of gastrointestinal motility disorders during pregnancy, their clinical manifestations, and their management. Data Sources: Studies published from 1963 to 1992 identified by computerized literature searches of Index Medicus and MEDLINE; hand searches; contact with pharmaceutical representatives for information on drug therapy during pregnancy; and selected texts on drugs and obstetrics. Study Selection: Selected studies were those involving controlled design of physiology related to pregnancy or to hormonal effects on the gastrointestinal tract or both, and clinical studies or previous reviews that contributed to the understanding of the gastrointestinal effects of pregnancy. Data Extraction: Data concerning the epidemiology, causes, clinical manifestations, and complications of altered gastrointestinal motility during pregnancy as well as the strength of association between gastrointestinal disorders of pregnancy and hormonal changes were evaluated and used to develop a practical approach to evaluate and manage these patients. Results of Data Synthesis: Effects on the gastrointestinal tract during pregnancy are caused primarily by hormonal changes and not the physical effects of the gravid uterus. Motility changes occur throughout the gastrointestinal tract, including a reduction in lower esophageal sphincter pressure and its physiologic function with resulting gastroesophageal reflux and the risk for aspiration; alterations in gastric motor function associated with nausea and vomiting; and a decrease in the rate of small-bowel and colonic transit manifested primarily as abdominal bloating and constipation. These effects are mediated by progesterone, with estrogen probably acting as a primer. Conclusions: Given the large number of pregnancies each year complicated by gastrointestinal motility disorders, many physicians (including internists and gastroenterologists) must manage these problems. Knowledge of the underlying physiologic alterations in gastrointestinal motility during pregnancy and of safe treatment options is essential to the care of the pregnant patient.
引用
收藏
页码:366 / 375
页数:10
相关论文
共 85 条
  • [1] METOCLOPRAMIDE - PHARMACOLOGY AND CLINICAL-APPLICATION
    ALBIBI, R
    MCCALLUM, RW
    [J]. ANNALS OF INTERNAL MEDICINE, 1983, 98 (01) : 86 - 95
  • [2] PRENATAL AND NEONATAL EXPOSURE TO CIMETIDINE RESULTS IN GONADAL AND SEXUAL DYSFUNCTION IN ADULT MALES
    ANAND, S
    VANTHIEL, DH
    [J]. SCIENCE, 1982, 218 (4571) : 493 - 494
  • [3] ANDERSON AS, 1984, HLTH VISITOR, V12, P363
  • [4] ARMENTANO G, 1989, CLIN EXP OBSTET GYN, V4, P1306
  • [5] PLACENTAL-TRANSFER AND HORMONAL EFFECTS OF METOCLOPRAMIDE
    ARVELA, P
    JOUPPILA, R
    KAUPPILA, A
    PAKARINEN, A
    PELKONEN, O
    TUIMALA, R
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (03) : 345 - 348
  • [6] PREGNANCY HEARTBURN IN NIGERIANS AND CAUCASIANS WITH THEORIES ABOUT ETIOLOGY BASED ON MANOMETRIC RECORDINGS FROM ESOPHAGUS AND STOMACH
    BASSEY, OO
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1977, 84 (06): : 439 - 443
  • [7] BERKOWITZ RL, 1981, HDB PRESCRIBING MED
  • [8] THYROID-FUNCTION IN PATIENTS WITH HYPEREMESIS GRAVIDARUM
    BOUILLON, R
    NAESENS, M
    VANASSCHE, FA
    DEKEYSER, L
    DEMOOR, P
    RENAER, M
    DEVOS, P
    DEROO, M
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1982, 143 (08) : 922 - 926
  • [9] POSTPARTUM RESTORATION OF PREGNANCY-INDUCED CHOLECYSTOPARESIS AND PROLONGED INTESTINAL TRANSIT-TIME
    BRAVERMAN, DZ
    HERBET, D
    GOLDSTEIN, R
    PERSITZ, E
    EYLATH, U
    JACOBSOHN, WZ
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1988, 10 (06) : 642 - 646
  • [10] Briggs GG, 1983, DRUGS PREGNANCY LACT